181 related articles for article (PubMed ID: 31595696)
1. The polymorphisms (rs3213801 and rs5744533) of DNA polymerase kappa gene are not related with glioma risk and prognosis: A case-control study.
Wu Y; Zhou L; Deng Y; Li N; Yang P; Dong S; Yang S; Zheng Y; Yao L; Zhang M; Zhai Z; Dai Z; Wu Y
Cancer Med; 2019 Dec; 8(17):7446-7453. PubMed ID: 31595696
[TBL] [Abstract][Full Text] [Related]
2. Association Between Single Nucleotide Polymorphisms in DNA Polymerase Kappa Gene and Breast Cancer Risk in Chinese Han Population: A STROBE-Compliant Observational Study.
Dai ZJ; Liu XH; Ma YF; Kang HF; Jin TB; Dai ZM; Guan HT; Wang M; Liu K; Dai C; Yang XW; Wang XJ
Medicine (Baltimore); 2016 Jan; 95(2):e2466. PubMed ID: 26765445
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of ATP binding cassette transporter MDR1(1236C>T) gene polymorphism with glioma patients receiving Temozolomide-based chemoradiation therapy in Indian population.
Munisamy M; Munisamy S; Kumar JP; Jose A; Thomas L; Baburaj G; Subbiah V
Pharmacogenomics J; 2021 Apr; 21(2):262-272. PubMed ID: 33589792
[TBL] [Abstract][Full Text] [Related]
4. Correlations of MGMT genetic polymorphisms with temozolomide resistance and prognosis of patients with malignant gliomas: a population-based study in China.
Wang HW; Xu ZK; Song Y; Liu YG
Cancer Gene Ther; 2017 May; 24(5):215-220. PubMed ID: 28409559
[TBL] [Abstract][Full Text] [Related]
5. IL-10 and PRKDC polymorphisms are associated with glioma patient survival.
Hu M; Du J; Cui L; Huang T; Guo X; Zhao Y; Ma X; Jin T; Li G; Song J
Oncotarget; 2016 Dec; 7(49):80680-80687. PubMed ID: 27811370
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in the IL4R gene and clinical features are associated with glioma prognosis: Analyses of case-cohort studies.
Jin TB; Du S; Zhu XK; Li G; Ouyang Y; He N; Zhang Z; Zhang Y; Kang L; Yuan D
Medicine (Baltimore); 2016 Aug; 95(31):e4231. PubMed ID: 27495027
[TBL] [Abstract][Full Text] [Related]
7. Impact of AKAP6 polymorphisms on Glioma susceptibility and prognosis.
Zhang M; Zhao Y; Zhao J; Huang T; Wu Y
BMC Neurol; 2019 Nov; 19(1):296. PubMed ID: 31759389
[TBL] [Abstract][Full Text] [Related]
8. Impact of ANXA5 polymorphisms on glioma risk and patient prognosis.
Guo X; Song J; Zhao J; Wang B; Yang Z; Sun P; Hu M
J Neurooncol; 2019 Mar; 142(1):11-26. PubMed ID: 30536196
[TBL] [Abstract][Full Text] [Related]
9. Upfront Therapy of Aggressive/High-Risk Low-Grade Glioma: Single-Institution Outcome Analysis of Temozolomide-Based Radio-Chemotherapy and Adjuvant Chemotherapy.
Anand S; Chatterjee A; Gupta T; Panda P; Moiyadi A; Epari S; Patil V; Krishnatry R; Goda JS; Jalali R
World Neurosurg; 2021 Oct; 154():e176-e184. PubMed ID: 34245877
[TBL] [Abstract][Full Text] [Related]
10. The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis.
Ding X; Han X; Yuan H; Zhang Y; Gao Y
Sci Rep; 2020 Mar; 10(1):5140. PubMed ID: 32198386
[TBL] [Abstract][Full Text] [Related]
11. Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis.
Xavier-Magalhães A; Oliveira AI; de Castro JV; Pojo M; Gonçalves CS; Lourenço T; Viana-Pereira M; Costa S; Linhares P; Vaz R; Nabiço R; Amorim J; Pinto AA; Reis RM; Costa BM
J Neurooncol; 2017 Mar; 132(1):27-34. PubMed ID: 28083786
[TBL] [Abstract][Full Text] [Related]
12. Association of POLK polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients.
Shao M; Jin B; Niu Y; Ye J; Lu D; Han B
Cell Biochem Biophys; 2014 Nov; 70(2):1227-37. PubMed ID: 24948471
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
Wahl M; Phillips JJ; Molinaro AM; Lin Y; Perry A; Haas-Kogan DA; Costello JF; Dayal M; Butowski N; Clarke JL; Prados M; Nelson S; Berger MS; Chang SM
Neuro Oncol; 2017 Feb; 19(2):242-251. PubMed ID: 27571885
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Prognosis of Neuroglioma Based on Dynamic Magnetic Resonance Enhancement.
Li F; Zhang Y; Wang N; Song C; Gao Y; Diao X; Zhang H
World Neurosurg; 2020 Jun; 138():663-671. PubMed ID: 31981784
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Genetic Variants in MIR3142HG in Susceptibility to and Prognosis of Glioma.
Guo X; Zhang M; Li Q; Zhao J; Wang B; Wang J; Mao P; Song J
Am J Clin Oncol; 2020 Jan; 43(1):1-8. PubMed ID: 31513017
[TBL] [Abstract][Full Text] [Related]
16. Role of PVT1 polymorphisms in the glioma susceptibility and prognosis.
Ding X; Zhao Y; Yuan H; Zhang Y; Gao Y
Eur J Cancer Prev; 2021 Sep; 30(5):400-408. PubMed ID: 33443959
[TBL] [Abstract][Full Text] [Related]
17. Impact of four lncRNA polymorphisms (rs2151280, rs7763881, rs1136410, and rs3787016) on glioma risk and prognosis: A case-control study.
Deng Y; Zhou L; Li N; Wang M; Yao L; Dong S; Zhang M; Yang P; Hao Q; Wu Y; Lyu L; Jin T; Dai Z; Kang H
Mol Carcinog; 2019 Dec; 58(12):2218-2229. PubMed ID: 31489712
[TBL] [Abstract][Full Text] [Related]
18. The effects of gene polymorphisms on glioma prognosis.
Cui Y; Li G; Yan M; Li J; Jin T; Li S; Mu S
J Gene Med; 2017 Nov; 19(11):345-352. PubMed ID: 28985021
[TBL] [Abstract][Full Text] [Related]
19. Effect of epidermal growth factor receptor gene polymorphisms on prognosis in glioma patients.
Li B; Zhao W; Li J; Yan M; Xie Z; Zhu Y; Chen C; Jin T
Oncotarget; 2016 Sep; 7(39):63054-63064. PubMed ID: 27437777
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Fn14 in gliomas: tumor progression and poor prognosis.
Tan D; Pang FM; Li D; Zhang L; Wu J; Liu ZQ; Li X; Yan H
Future Oncol; 2018 Jun; 14(13):1273-1284. PubMed ID: 29741404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
